|
US1998A
(en)
|
|
1841-03-12 |
|
Refrigerator |
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4954617A
(en)
|
1986-07-07 |
1990-09-04 |
Trustees Of Dartmouth College |
Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
AU612370B2
(en)
|
1987-05-21 |
1991-07-11 |
Micromet Ag |
Targeted multifunctional proteins
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
WO1991009974A1
(en)
|
1989-12-27 |
1991-07-11 |
The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce |
Diagnostic probe for detecting human stomach cancer
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
GB9019812D0
(en)
|
1990-09-11 |
1990-10-24 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of infection in animals and man
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
GB9223377D0
(en)
|
1992-11-04 |
1992-12-23 |
Medarex Inc |
Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
|
|
US5589579A
(en)
|
1994-07-19 |
1996-12-31 |
Cytoclonal Pharmaceutics, Inc. |
Gene sequence and probe for a marker of non-small cell lung carinoma
|
|
WO2000075316A1
(en)
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5677139A
(en)
|
1995-04-21 |
1997-10-14 |
President And Fellows Of Harvard College |
In vitro differentiation of CD34+ progenitor cells into T lymphocytes
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
CA2242340A1
(en)
|
1996-01-11 |
1997-07-17 |
Corixa Corporation |
Compositions and methods for the treatment and diagnosis of breast cancer
|
|
WO2000073348A2
(en)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
US7368531B2
(en)
*
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
|
US7411051B2
(en)
|
1997-03-07 |
2008-08-12 |
Human Genome Sciences, Inc. |
Antibodies to HDPPA04 polypeptide
|
|
US20070224663A1
(en)
|
1997-03-07 |
2007-09-27 |
Human Genome Sciences, Inc. |
Human Secreted Proteins
|
|
WO2000078961A1
(en)
|
1999-06-23 |
2000-12-28 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000012708A2
(en)
|
1998-09-01 |
2000-03-09 |
Genentech, Inc. |
Further pro polypeptides and sequences thereof
|
|
US20030073129A1
(en)
|
1998-09-01 |
2003-04-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030022298A1
(en)
|
1997-09-15 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020127584A1
(en)
|
1997-09-18 |
2002-09-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030008352A1
(en)
|
1997-09-18 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030027272A1
(en)
|
1997-09-18 |
2003-02-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030166104A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030032103A1
(en)
|
1997-09-18 |
2003-02-13 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20050196832A1
(en)
|
1997-09-18 |
2005-09-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7160985B2
(en)
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US20030022835A1
(en)
|
1998-04-29 |
2003-01-30 |
Genesis Research And Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
|
US20030040471A1
(en)
|
1998-04-29 |
2003-02-27 |
Watson James D. |
Compositions isolated from skin cells and methods for their use
|
|
JP3428441B2
(ja)
|
1998-05-15 |
2003-07-22 |
エーザイ株式会社 |
タイトジャンクション構成膜蛋白質クローディンファミリー
|
|
US7351543B2
(en)
|
1998-06-02 |
2008-04-01 |
Genentech, Inc. |
Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
|
|
US7319008B2
(en)
|
1998-06-02 |
2008-01-15 |
Genentech, Inc. |
Nucleic acid underexpressed in melanoma
|
|
WO1999064452A1
(en)
*
|
1998-06-11 |
1999-12-16 |
Smithkline Beecham Corporation |
Gpr35a receptor
|
|
US7339033B2
(en)
|
1998-06-26 |
2008-03-04 |
Genentech, Inc. |
Pro1481
|
|
EP1104486A4
(en)
|
1998-08-04 |
2002-07-17 |
Diadexus Llc |
NEW METHOD FOR DIAGNOSIS, FOLLOW-UP, AND IMAGE OF LUNG CANCER
|
|
US20030082626A1
(en)
|
1998-09-01 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7026455B2
(en)
|
1998-09-01 |
2006-04-11 |
Genentech, Inc. |
Anti-pro 1343 antibodies
|
|
US7071304B2
(en)
|
1998-09-01 |
2006-07-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20050181478A1
(en)
|
1998-09-01 |
2005-08-18 |
Baker Kevin P. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU6143399A
(en)
*
|
1998-09-16 |
2000-04-03 |
Zymogenetics Inc. |
Stomach polypeptide zsig28
|
|
IL141535A0
(en)
|
1998-09-16 |
2002-03-10 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
JP2004500011A
(ja)
|
1998-10-06 |
2004-01-08 |
キュラゲン コーポレイション |
新規な分泌タンパク質、およびそれをコードするポリヌクレオチド
|
|
US7399834B2
(en)
|
1998-10-07 |
2008-07-15 |
Genentech, Inc. |
Anti-PRO1558 antibodies
|
|
US6235481B1
(en)
|
1998-10-21 |
2001-05-22 |
Arch Development Corporation & Board Of Regents |
Polynucleotides encoding calpain 10
|
|
US20030009013A1
(en)
|
1998-12-30 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7026449B2
(en)
|
1999-01-05 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
KR20030002292A
(ko)
|
1999-03-08 |
2003-01-08 |
제넨테크, 인크. |
분비 및 막횡단 폴리펩티드 및 이를 코딩하는 핵산
|
|
US7507404B2
(en)
|
1999-03-08 |
2009-03-24 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
KR20010104373A
(ko)
|
1999-03-08 |
2001-11-24 |
제넨테크, 인크. |
혈관신생 및 심혈관형성의 촉진 또는 억제 방법
|
|
DK1609863T3
(da)
|
1999-03-23 |
2008-12-15 |
Genentech Inc |
Udskilte polypeptider og transmembranpolypeptider samt nucleinsyrer kodende for disse
|
|
EP1165784A2
(en)
|
1999-03-31 |
2002-01-02 |
Curagen Corporation |
Nucleic acids including open reading frames encoding polypeptides; "orfx"
|
|
US20080286821A1
(en)
|
1999-05-14 |
2008-11-20 |
Eaton Dan L |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU3246100A
(en)
|
1999-06-02 |
2000-12-28 |
Genentech Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
JP2004522402A
(ja)
|
1999-06-02 |
2004-07-29 |
ジェネンテック・インコーポレーテッド |
同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
|
|
EP1208195A2
(en)
|
1999-06-15 |
2002-05-29 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU2883900A
(en)
|
1999-07-07 |
2001-01-30 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
CA2380355A1
(en)
*
|
1999-09-01 |
2001-03-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001027257A1
(en)
|
1999-10-14 |
2001-04-19 |
The Board Of Trustees Of The University Of Arkansas |
Tumor antigen derived gene-16 (tadg-16): a novel extracellular serine protease and uses thereof
|
|
CA2491610A1
(en)
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
|
JP4280444B2
(ja)
|
2000-01-06 |
2009-06-17 |
ジェネンテック・インコーポレーテッド |
腫瘍性細胞成長阻害のための組成物及び方法
|
|
WO2001055326A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
WO2001055309A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
EP1251863A4
(en)
|
2000-01-31 |
2005-03-02 |
Human Genome Sciences Inc |
22 SEPARATE HUMAN PROTEINS
|
|
US20030050231A1
(en)
|
2000-01-31 |
2003-03-13 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
CA2401070A1
(en)
|
2000-02-22 |
2001-08-30 |
Corixa Corporation |
Compositions and methods for diagnosis and therapy of malignant mesothelioma
|
|
AU6802801A
(en)
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU4592601A
(en)
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
JP2003530838A
(ja)
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
|
WO2001090357A1
(en)
|
2000-05-24 |
2001-11-29 |
Genesis Research & Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
|
US6822082B2
(en)
|
2000-06-30 |
2004-11-23 |
Zymogenetics, Inc. |
Polynucleotides for mammalian secreted protein, Z1055G2P
|
|
WO2002012437A2
(en)
|
2000-08-03 |
2002-02-14 |
Schooten Wim Van |
Production of humanized antibodies in transgenic animals
|
|
DE60128701T2
(de)
|
2000-08-15 |
2008-02-07 |
Immunex Corp., Thousand Oaks |
Claudin polypeptide
|
|
AU2001285047A1
(en)
|
2000-08-16 |
2002-02-25 |
Chiron Corporation |
Human genes and gene expression products
|
|
AU2001229509A1
(en)
*
|
2000-08-18 |
2002-03-04 |
Human Genome Sciences, Inc. |
11 human secreted proteins
|
|
US20030017468A1
(en)
|
2000-08-28 |
2003-01-23 |
Sei-Yu Chen |
Compositions and methods relating to lung specific genes
|
|
ATE549347T1
(de)
|
2000-09-08 |
2012-03-15 |
Schering Corp |
Gene von säugetiere, und damit verbundene reagentien, methoden
|
|
US7829276B2
(en)
|
2000-09-18 |
2010-11-09 |
Thomas Jefferson University |
Methods of using CRCA-1 as a stomach and esophageal cancer marker
|
|
JP3523245B1
(ja)
|
2000-11-30 |
2004-04-26 |
メダレックス，インコーポレーテッド |
ヒト抗体作製用トランスジェニック染色体導入齧歯動物
|
|
WO2002061087A2
(en)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
|
|
WO2002068579A2
(en)
|
2001-01-10 |
2002-09-06 |
Pe Corporation (Ny) |
Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
AU2002258387A1
(en)
|
2001-01-29 |
2002-09-04 |
Phase-1 Molecular Toxicology, Inc. |
Rat toxicologically relevant genes and uses thereof
|
|
WO2002068600A2
(en)
*
|
2001-02-26 |
2002-09-06 |
Arena Pharmaceuticals, Inc. |
Endogenous and non-endogenous versions of human g protein-coupled receptors
|
|
US20030152939A1
(en)
|
2001-04-09 |
2003-08-14 |
Glennda Smithson |
Novel secreted proteins and polynucleotides encoding them
|
|
US20060084794A1
(en)
|
2001-04-12 |
2006-04-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP2003000249A
(ja)
|
2001-05-10 |
2003-01-07 |
Daiichi Fine Chemical Co Ltd |
クローディンによるＭＴ−ＭＭＰｓを介したｐｒｏＭＭＰ−２活性化
|
|
CA2449042A1
(en)
|
2001-05-30 |
2002-12-27 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
|
CA2450236A1
(en)
|
2001-07-06 |
2003-01-16 |
Genentech, Inc. |
Phage displayed pdz domain ligands
|
|
EP1443951A4
(en)
|
2001-08-03 |
2006-05-03 |
Arbor Vita Corp |
MOLECULAR INTERACTIONS IN CELLS
|
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US20030023042A1
(en)
|
2001-12-06 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
|
TW200304948A
(en)
*
|
2002-02-28 |
2003-10-16 |
Sankyo Co |
The marker for the prediction of heart failure condition and the use thereof
|
|
CA2379661A1
(en)
|
2002-03-28 |
2003-09-28 |
Kursad Turksen |
Paracellular drug delivery system
|
|
WO2003101283A2
(en)
|
2002-06-04 |
2003-12-11 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
|
WO2004029207A2
(en)
|
2002-09-27 |
2004-04-08 |
Xencor Inc. |
Optimized fc variants and methods for their generation
|
|
PL216630B1
(pl)
|
2002-10-17 |
2014-04-30 |
Genmab As |
Izolowane ludzkie przeciwciało monoklonalne wiążące ludzki CD20, związane z tym przeciwciałem transfektoma, komórka gospodarza, transgeniczne zwierzę lub roślina, kompozycja, immunokoniugat, cząsteczka bispecyficzna, wektor ekspresyjny, kompozycja farmaceutyczna, zastosowanie medyczne, zestaw oraz przeciwciało antyidiotypowe i jego zastosowanie
|
|
EP1578365A4
(en)
|
2002-11-14 |
2009-09-23 |
Arbor Vita Corp |
MOLECULAR INTERACTIONS IN NEURONS
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
EP1430902A1
(en)
|
2002-12-20 |
2004-06-23 |
Mondobiotech Laboratories Anstalt |
Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale
|
|
EP2368578A1
(en)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
EP2003196A3
(en)
|
2003-06-09 |
2009-01-07 |
The Regents of the University of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
WO2005032495A2
(en)
|
2003-10-03 |
2005-04-14 |
Bayer Pharmaceuticals Corporation |
Gene expression profiles and methods of use
|
|
DE10354601B3
(de)
|
2003-11-21 |
2005-06-23 |
Chiropro Gmbh |
Gelenkprothese für Fingerglieder
|
|
WO2005052182A2
(en)
|
2003-11-26 |
2005-06-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
A method of analyzing plasma membrane protein content of cells
|
|
US20080119412A1
(en)
|
2003-12-23 |
2008-05-22 |
Nono Inc. |
Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins
|
|
WO2005076939A2
(en)
|
2004-02-09 |
2005-08-25 |
University Of Kentucky Research Foundation |
Assay and method for diagnosing and treating alzheimer’s disease
|
|
WO2005082398A2
(en)
|
2004-02-26 |
2005-09-09 |
Ohio University |
Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells
|
|
US20050255041A1
(en)
|
2004-05-13 |
2005-11-17 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
DE602005013670D1
(de)
|
2004-05-21 |
2009-05-14 |
Inst Systems Biology |
Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
|
|
WO2006023121A1
(en)
|
2004-07-27 |
2006-03-02 |
Ohio University |
Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in white adipose tissue (13)
|
|
DE102004042822A1
(de)
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
|
FR2876705B1
(fr)
|
2004-10-19 |
2008-12-12 |
Biomerieux Sa |
Procede pour le diagnostic d'une intolerance a l'aspirine
|
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
|
EP1910837B1
(en)
|
2005-07-01 |
2012-03-14 |
Arbor Vita Corporation |
Methods and compositions for diagnosis and treatment of influenza
|
|
CA2619577A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
WO2007027867A2
(en)
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20080050726A1
(en)
|
2005-09-19 |
2008-02-28 |
Yixin Wang |
Methods for diagnosing pancreatic cancer
|
|
AU2006304605A1
(en)
|
2005-10-17 |
2007-04-26 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
US20070264193A1
(en)
|
2006-03-29 |
2007-11-15 |
Genentech, Inc. |
Diagnostics and treatments for tumors
|
|
WO2008013948A2
(en)
|
2006-07-27 |
2008-01-31 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
WO2008021290A2
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
US8450057B2
(en)
|
2006-08-14 |
2013-05-28 |
The Brigham And Women's Hospital, Inc. |
Diagnostic tests using gene expression ratios
|
|
CN101541977A
(zh)
|
2006-09-19 |
2009-09-23 |
诺瓦提斯公司 |
用于raf抑制剂的靶向调节、效力、诊断和/或预后的生物标志物
|
|
US20110150897A1
(en)
|
2006-10-11 |
2011-06-23 |
Meyer Thomas F |
Influenza targets
|
|
EP2097538A4
(en)
|
2006-12-07 |
2011-11-30 |
Switchgear Genomics |
TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
|
|
CA2671194A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-20 regulated genes and pathways as targets for therapeutic intervention
|
|
CN101687050A
(zh)
|
2007-02-01 |
2010-03-31 |
维里德克斯有限责任公司 |
用于鉴别原发起源不明的癌的起源的方法和材料
|
|
EP1983002A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
EP1997832A1
(en)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against Claudin-18 for treatment of cancer
|
|
US20090227533A1
(en)
|
2007-06-08 |
2009-09-10 |
Bader Andreas G |
miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention
|
|
WO2008152822A1
(ja)
|
2007-06-15 |
2008-12-18 |
Medinet Co., Ltd. |
医薬
|
|
WO2009015050A2
(en)
|
2007-07-20 |
2009-01-29 |
The Gov. Of The U.S.A. As Represented By The Secretary Of The Department Of Health & Human Services |
Gene expression profile for predicting ovarian cancer patient survival
|
|
WO2009035497A2
(en)
|
2007-08-08 |
2009-03-19 |
Savidge Tor C |
Disease related cysteine modifications and uses thereof
|
|
EP2036987A1
(en)
|
2007-09-17 |
2009-03-18 |
Siemens Healthcare Diagnostics GmbH |
Molecular markers for tumor cell content in tissue samples
|
|
CN101801370B
(zh)
|
2007-09-19 |
2013-06-12 |
三得利控股株式会社 |
含有芝麻素类和花生四烯酸类的组合物
|
|
WO2009047362A2
(en)
|
2007-10-12 |
2009-04-16 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin |
Method for opening tight junctions
|
|
US8563515B2
(en)
|
2007-11-19 |
2013-10-22 |
The Regents Of The University Of Colorado, A Body Corporate |
Tight junction protein modulators and uses thereof
|
|
CA2726817A1
(en)
|
2008-06-02 |
2009-12-10 |
Nsabp Foundation, Inc. |
Identification and use of prognostic and predictive markers in cancer treatment
|
|
US20110190380A1
(en)
|
2008-10-23 |
2011-08-04 |
Elena Feinstein |
Methods for delivery of sirna to bone marrow cells and uses thereof
|
|
CN101381524A
(zh)
|
2008-10-24 |
2009-03-11 |
南开大学 |
单层氧化石墨与水溶性高分子增强复合材料
|
|
GB0904957D0
(en)
|
2009-03-23 |
2009-05-06 |
Univ Erasmus Medical Ct |
Tumour gene profile
|
|
WO2010120526A2
(en)
|
2009-03-31 |
2010-10-21 |
Emory University |
Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders
|
|
CN101584860A
(zh)
|
2009-04-27 |
2009-11-25 |
西安杰诺瓦生物科技有限公司 |
重组人Claudin18.2肿瘤疫苗及其制备方法
|
|
WO2010141093A2
(en)
|
2009-06-04 |
2010-12-09 |
The University Of Maryland, Baltimore |
Co-signaling methods for treating cancers
|
|
WO2011038461A1
(en)
|
2009-10-01 |
2011-04-07 |
Chipdx Llc |
System and method for classification of patients
|
|
US20120245235A1
(en)
|
2009-12-01 |
2012-09-27 |
Compenda Bioscience, Inc |
Classification of cancers
|
|
EP2366709A1
(en)
|
2010-03-16 |
2011-09-21 |
BioNTech AG |
Tumor vaccination involving a humoral immune response against self-proteins
|
|
AU2011229518B2
(en)
|
2010-03-16 |
2015-09-24 |
Biontech Protein Therapeutics Gmbh |
Tumor vaccination involving a humoral immune response against self-proteins
|
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
|
CN103068850A
(zh)
*
|
2010-05-26 |
2013-04-24 |
明尼苏达大学评议会 |
单链可变片段抗-cd133抗体及其用途
|
|
EP2576824A2
(en)
|
2010-06-07 |
2013-04-10 |
Roche Diagnostics GmbH |
Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
WO2011163627A2
(en)
|
2010-06-24 |
2011-12-29 |
Integrated Diagnostics, Inc. |
Organ specific diagnostic panels and methods for identification of organ specific panel proteins
|
|
WO2012070014A2
(en)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
|
|
EP2664676B1
(en)
|
2011-01-12 |
2017-05-17 |
Morinaga Milk Industry Co., Ltd. |
Method for screening for diet or substance providing production of milk having immunoregulatory action
|
|
DE102011005235B4
(de)
|
2011-03-08 |
2017-05-24 |
Sirs-Lab Gmbh |
Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
|
|
EP2834259A4
(en)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
WO2013174403A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014025198A2
(ko)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
Lfa3 변이체 및 상기 변이체 또는 lfa3 cd2 결합영역과 이에 표적 특이적 폴리펩타이드가 연결된 융합단백질 및 그 용도
|
|
WO2014025199A2
(ko)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
스테필로코칼 엔테로톡신 유래의 초항원 변이체 및 이에 표적 특이적 폴리펩타이드가 연결된 융합단백질 및 그 용도
|
|
WO2014031859A2
(en)
|
2012-08-24 |
2014-02-27 |
University Of Utah Research Foundation |
Compositions and methods relating to blood-based biomarkers of breast cancer
|
|
US9856532B2
(en)
|
2012-09-07 |
2018-01-02 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (PTSD)
|
|
US20140073524A1
(en)
|
2012-09-07 |
2014-03-13 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (ptsd)
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|